Skip to content

Frontlight ResearchEarly access

Trial site

Sittard-Geleen

Sittard-Geleen, 6162 BG, NetherlandsNot linked to an institution yet

1closed trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Crohn's disease

Closed trials

Completed
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
NCT03440385· Phase 3· Celgene· Source

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error

Sittard-Geleen: trial site – Frontlight Research